Gene · 10076
Papers2,589
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,589
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesis. | bioRxiv | 2023 | 36747658 | PubTator, text mining | PubMed |
| Serine/threonine-protein kinase STK24 induces tumorigenesis by regulating the STAT3/VEGFA signaling pathway. | J Biol Chem | 2023 | 36720310 | PubTator, text mining | PubMed |
| Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders. | Nat Rev Drug Discov | 2023 | 36693907 | PubTator, text mining | PubMed |
| Exosomal transmission of viruses, a two-edged biological sword. | Cell Commun Signal | 2023 | 36691072 | PubTator, text mining | PubMed |
| Molecular Landscape of Tourette's Disorder. | Int J Mol Sci | 2023 | 36674940 | PubTator, text mining | PubMed |
| The Role of Oxidative Inactivation of Phosphatase PTEN and TCPTP in Fatty Liver Disease. | Antioxidants (Basel) | 2023 | 36670982 | PubTator, text mining | PubMed |
| Roles of protein tyrosine phosphatases in hepatocellular carcinoma progression (Review). | Oncol Rep | 2023 | 36660927 | PubTator, text mining | PubMed |
| Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE. | Thromb J | 2023 | 36658654 | PubTator, text mining | PubMed |
| SHP-1 tyrosine phosphatase binding to c-Src kinase phosphor-dependent conformations: A comparative structural framework. | PLoS One | 2023 | 36638102 | PubTator, text mining | PubMed |
| How weekly monitoring variables influence players' and teams' match performance in elite futsal players. | Biol Sport | 2023 | 36636201 | PubTator, text mining | PubMed |
| SHP2 deneddylation mediates tumor immunosuppression in colon cancer via the CD47/SIRPα axis. | J Clin Invest | 2023 | 36626230 | PubTator, text mining | PubMed |
| The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer's Disease: New Potential Treatment Target. | Int J Mol Sci | 2023 | 36614305 | PubTator, text mining | PubMed |
| PTPN11 Mosaicism Causes a Spectrum of Pigmentary and Vascular Neurocutaneous Disorders and Predisposes to Melanoma. | J Invest Dermatol | 2023 | 36566878 | PubTator, text mining | PubMed |
| KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition. | Cancer Cell | 2023 | 36525973 | PubTator, text mining | PubMed |
| A Study to Evaluate Relative Bioavailability, Food Effect, and Pharmacodynamics of Tropifexor, a Farnesoid X Receptor Agonist, in Healthy Participants. | Clin Pharmacol Drug Dev | 2023 | 36495282 | PubTator, text mining | PubMed |
| Role of SHP2/PTPN11 in the occurrence and prognosis of cancer: A systematic review and meta-analysis. | Oncol Lett | 2023 | 36478896 | PubTator, text mining | PubMed |
| Discovery of the SHP2 allosteric inhibitor 2-((3R,4R)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-5-(2,3-dichlorophenyl)-3-methylpyrrolo[2,1-f][1,2,4] triazin-4(3H)-one. | J Enzyme Inhib Med Chem | 2023 | 36476046 | PubTator, text mining | PubMed |
| Determinants of receptor tyrosine phosphatase homophilic adhesion: Structural comparison of PTPRK and PTPRM extracellular domains. | J Biol Chem | 2023 | 36436563 | PubTator, text mining | PubMed |
| Biology and Targetability of the Extended Spectrum of PIK3CA Mutations Detected in Breast Carcinoma. | Clin Cancer Res | 2023 | 36321996 | PubTator, text mining | PubMed |
| Targeting RAS mutants in malignancies: successes, failures, and reasons for hope. | Cancer Commun (Lond) | 2023 | 36316602 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10076/papers?page=15